Kronos Bio Inc.
kronosbio.com
Latest From Kronos Bio Inc.
Harper, Hooper Exit As Amgen Revenues Rise
Amgen revealed better-than-expected second quarter earnings July 26 and said its R&D and commercial heads Sean Harper and Anthony Hooper are retiring. Harper, who's getting involved with start-ups, is being replaced from within by David Reese; Bristol's Murdo Gordon will take over for Hooper.
Harper, Hooper Exit As Amgen Revenues Rise
Amgen revealed better-than-expected second quarter earnings July 26 and said its R&D and commercial heads Sean Harper and Anthony Hooper are retiring. Harper, who's getting involved with start-ups, is being replaced from within by David Reese; Bristol's Murdo Gordon will take over for Hooper.
Company Information
- Industry
-
Biotechnology
-
Drug Discovery Tools
- Molecular Diversity
-
Drug Discovery Tools
- Pharmaceuticals
- Therapeutic Areas
- Cancer
- Alias(es)
- Ownership
- Private
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Company Type
- Start-Up
- Parent & Subsidiaries
- Kronos Bio Inc.
- Senior Management
-
Norbert Bischofberger, PhD, Pres. & CEO
Christopher Wilfong, COO - Contact Info
-
Kronos Bio Inc.
689 Fifth Ave.
12th Fl.
New York, NY 10022
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice